Intended laboratory context
Illustrative applications
- Analytical comparison
- Method development
- In-vitro laboratory investigation
- Research protocol development
Lyophilized Peptides
KPV 10MG
Lys-Pro-Val-OH; α-MSH (11–13); tripeptide KPV
The C-terminal Lys-Pro-Val tripeptide fragment of α-melanocyte-stimulating hormone, supplied as a defined research material.
CatalogKPV-PW-10MG
ManufacturerRemetide
PurityProposed ≥99% by RP-HPLC; lot result controls
Pack10 mg
$45.00 Current catalog price; lot availability controls fulfillment.
AvailabilityIn stock
5293 in stock
For laboratory research use only. Not for human or veterinary use.
KPV 10MG$45.00
01Lot documentationCOA and analytical-record model
02Defined specificationMethod and result remain lot specific
03Tracked fulfillmentShipping method and lot allocation confirmed at order review
04Responsible useNon-clinical laboratory context
Technical information
Chemical & material record
Presented in a scientific-catalog format so the material can be evaluated by identity, form and documentation before purchase.
- Identity
- KPV research peptide; salt form controlled by the approved specification
- Synonyms
- Lys-Pro-Val-OH; α-MSH (11–13); tripeptide KPV
- CAS number
- See approved Remetide material specification
- Molecular formula
- See approved Remetide salt-form specification
- Formula weight
- See approved Remetide salt-form specification
- Sequence / identity note
- KPV-OH; counter-ion controlled by the approved lot record
- Manufacturer
- Remetide
- Manufacturing role
- Custom peptide synthesis and manufacture
- Form
- Lyophilized, non-sterile research material
- Purity specification
- Proposed ≥99% by RP-HPLC; lot result controls
- Storage
- -20°C, dry and protected from light; follow lot documentation
- Pack size
- 10 mg
- Catalog number
- KPV-PW-10MG
Product description
Published context, clearly separated from lot claims.
A technical catalog should make the chemical record, relevant experimental literature and product-specific documentation independently reviewable.
KPV corresponds to residues 11–13 of α-melanocyte-stimulating hormone (α-MSH). Published research has examined this tripeptide in inflammatory, antimicrobial and neuroinflammation model systems.
In one in-vitro study, 1 µM KPV produced bactericidal activity against methicillin-resistant Staphylococcus aureus. Separate mouse studies evaluated colonic inflammation and experimental traumatic brain injury. These findings are model specific and do not establish clinical benefit.
Selected published findings
- Investigated for antibacterial activity against S. aureus in vitro.
- Evaluated in murine colitis and experimental traumatic-brain-injury models.
- Described in the literature as an α-MSH C-terminal tripeptide fragment.
References and product citations 3
- Kannengiesser, K., Maaser, C., Heidemann, J., et al. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflammatory Bowel Diseases 14(3), 324–331 (2008).
- Schaible, E.V., Steinsträßer, A., Jahn-Eimermacher, A., et al. Single administration of tripeptide α-MSH(11–13) attenuates brain damage after experimental traumatic brain injury in mice. PLOS ONE 8(8), e71056 (2013).
- Singh, M., and Mukhopadhyay, K. C-terminal amino acids of α-MSH are requisite for antibacterial activity against Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 55(5), 1920–1929 (2011).
Literature interpretation: This summary describes published experimental literature and is not a lot specification, clinical claim, use instruction or representation that the supplied research material will reproduce a published result. This record intentionally excludes dosing, administration, clinical outcomes, patient eligibility and therapeutic comparisons.
Proposed package
Documentation
- PDFCertificate of AnalysisSample
- PDFHPLC chromatogramSample
- PDFMass-spectrometry summarySample
- PDFHandling statementSample
For laboratory research workflows only. Not for administration to humans or animals and not supplied with dosing or reconstitution guidance.
Need a current record?
Documentation before decision-making.
Reference KPV-PW-10MG and the applicable lot when contacting technical support. Published files support evaluation but do not replace the approved lot COA or material specification.
View documentation model